CALC
CalciMedica, Inc.
$0.78
+0.04 (+5.04%)
At close · Jul 15
Going-concern doubt
— flagged May 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Our need for additional capital raises substantial doubt about our ability to continue as a going concern.”View the 10-Q filed May 12, 2026
Market Cap
$12.35M
Shares
15,798,031
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.78
Open$0.76
Day$0.73–0.79
52W$0.46–7.20
Avg vol 30d2.4M
Short int1.7M · 10.5% float · 1.0d
Short vol13%
Last earningsNov 7, 2025
DataJun 2023–Jul 2026
Filing10-Q · May 12
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 12, 2026
Equibles Rating
blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 15.7 · calm
Equity put/call 0.69
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−64%
below
Price vs 50-day avg
−2%
below
RSI (14)
45
neutral
MACD trend
Negative
52-week position
5%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−10%
trailing
6-month return
−86%
trailing
YTD return
−88%
this year
Relative strength
−96%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow
Distributing
1 of 28 funds reported for Jun 30 · net -43.1K sh shares
Insider flow
Accumulating
Net +$200.0K over 90 days · 0% sells
Short interest
Rising
10.46% of float · ▲ +497.8% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
28 holders — mid 3-yr range
Squeeze score
71
high risk · 0–100
Fundamentals
EPS growth
−61%
Y/Y
Free cash flow
$-21.2M
Balance sheet
$11.5M
net cash
Quant / Vol
risk profile
Volatility
144%
annualized · 1-yr
Max drawdown
−92%
past year
ATR
14.9%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−64%
Bearish
Price vs 50-day avg
−2%
Neutral
RSI (14)
45
Neutral
MACD trend
Negative
Bearish
52-week position
5%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow
Distributing
1 of 28 funds reported for Jun 30 · net -43.1K sh shares
Insider flow
Accumulating
Net +$200.0K over 90 days · 0% sells
Short interest
Rising
10.46% of float · ▲ +497.8% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
28 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $0
Now $1 · 5%
52-wk high $7
vs 200-day avg -64%
vs 50-day avg -2%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CALC
this stock
CalciMedica, Inc.
|
$12.35M | -88.1% | — | — | 10.5% |
|
ONC
BeOne Medicines Ltd.
|
$449.85B | +2.5% | +22179.2% | 915.5 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$121.09B | +5.2% | +46.2% | 28.3 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.66B | -13.8% | +20.8% | 16.2 | 3.3% |
|
ARGX
Argenx SE
|
$53.96B | +2.6% | — | — | 2.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CALC | -13.2% | -10.2% | -86.0% | -24.1% | -88.1% |
| SPY | +1.3% | -0.2% | +10.1% | +1.1% | +10.7% |
| vs SPY | -14.4% | -10.0% | -96.1% | -25.2% | -98.8% |